Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 21, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Addition of Renowned Breast Cancer Physician to Its Scientific Advisory Board

LAKE OSWEGO, Ore., March 21, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
March 20, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Strengthens NeuVax(TM) Intellectual Property Position With Notice of Allowance for U.S. Patent

Patent covers the use of NeuVax for treating Phase 3 target population of low-to-intermediate (IHC 1+/2+) HER2 patients. Provides NeuVax exclusivity for this indication until 2028, not...
March 07, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 24th Annual ROTH Conference

LAKE OSWEGO, Ore., March 7, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
February 29, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Expansion of Scientific Advisory Board

LAKE OSWEGO, Ore., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
February 28, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Cancer Targets and Therapeutics Conference

LAKE OSWEGO, Ore., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
February 27, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Establishes Record Date for Spin-Off Stock Dividend of RXi Pharmaceuticals Shares

One-for-one spin-off stock dividend to be distributed to Galena stockholders as of the Record Date of March 8, 2012 Galena to retain minority equity interest in RXi with potential to receive...
February 23, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Cancer Immunotherapy Summit

LAKE OSWEGO, Ore., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
February 17, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 2nd Annual Emerging Targeted Oncology Partnering Forum

LAKE OSWEGO, Ore., Feb. 17, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
February 14, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Initiates Enrollment in Phase 1/2 Trial for Folate Binding Protein (E39) Targeted Peptide Vaccine in Ovarian and Endometrial Cancer Patients

FBP vaccine designed to prevent recurrence in ovarian and aggressive endometrial cancer patients Phase 1/2 dose escalation study to monitor safety and efficacy LAKE OSWEGO, Ore., Feb. 14,...
February 09, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Launch of New Patient Website: NeuVax.com

Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low-to-Intermediate HER2 Expression with NeuVax Treatment) study now enrolling under an FDA approved...